The Christie Oncology Symposium

Dr. Mark Saunders

The Christie NHS Trust, Manchester


Dr. Mark Saunders is Consultant clinical oncologist at the University of Manchester received his medical degree from Charing Cross Hospital, London, UK, in 1986 and followed this with further training at teaching hospitals in London. He spent 5 years working in general medicine before specialising in oncology, first at the Churchill Hospital in Oxford and later at The Christie in Manchester. During his time as an Imperial Cancer Research Fund Fellow at the Churchill Hospital, Dr. Saunders gained a Medical Research Council (MRC) grant to fund work that led to his Ph.D., entitled “The application of gene therapy to selectively enhance tumour cell kill by bioreductive drugs”, which he completed in 1999. He was the recipient of the Karol Sicher Research Fellowship, awarded by the UK Royal College of Radiologists, which allowed him to spend three months working with Professor Ralph Weichselbaum at the University of Chicago. He was made a consultant at The Christie in 1999. His main area of interest is running clinical trials evaluating novel agents with associated response/toxicity biomarkers and radiology (colorectal cancer, anal cancer, and pseudomyxoma). He has written a series of protocols for clinical trials that have been funded, completed and published. He also chairs or is a member of a number of Trial Management Groups (TMGs) and Data Monitoring Committees (DMCs). Dr. Saunders is a member of a number of NCRN and CRUK committees and chairs the Northern Cancer Drug Fund (CDF) committee. He is also an advisor to Beating Bowel Cancer, a charity dedicated to raising awareness of bowel cancer, improving the quality of life of those affected and, ultimately, reducing deaths from bowel cancer.


Mr Malcom Wilson

The Christie NHS Trust, Manchester


Malcolm Wilson has been a Consultant Colorectal and Pelvic Oncological Surgeon at The Christie since April 2000, having previously had consultant posts at Macclesfield, Stepping Hill and the University Hospital of South Manchester. He was Director of Surgery at The Christie between 2006 and 2014. He is the Lead Clinician for Colorectal Surgery, joint Lead of the Peritoneal Tumour Service and a member of Pelvic Tumour Team. He is an Honorary Senior Lecturer at the School of Medicine, University of Manchester, and Consultant Appointment Assessor for the Royal College of Surgeons, England. Malcolm trained in London and Manchester with a brief period at the Cleveland Clinic, Fort Lauderdale, Florida. He has research interests in colorectal and anal cancer, peritoneal tumours and post-operative adhesions.



Mr Omer Aziz

The Christie NHS Trust, Manchester


Mr. Aziz is a consultant colorectal surgeon at The Christie, one of Europe's largest comprehensive cancer centres. At the Colorectal and Peritoneal Oncology Centre he specialises in colorectal cancer (primary, advanced, and recurrent disease), anal cancer, appendix tumours, peritoneal tumours, and coloproctology. He is experienced in open and laparoscopic cytoreductive surgery with hyperthermic intra-peritoneal chemotherapy (HIPEC), advanced laparoscopic techniques, and endoscopic procedures. To date, he has been involved in the development of evidence synthesis techniques to guide healthcare decision-making and published over 100 peer-reviewed research papers, some of which have been used by institutions such as the National Institute for Health and Care Excellence (NICE) in their guidance. He has raised research grants from Innovate UK, the Medical Research Council and the National Institute for Health Research as well as industry investment to translate innovative technologies into medical devices that improve outcomes for patients undergoing cancer treatment.


Dr. Richard Berman

The Christie NHS Trust, Manchester


Dr. Berman graduated in medicine from Charing Cross & Westminster Medical School in 1996. He joined a specialist training programme for palliative medicine in 2002 (Northwest deanery).

Dr Berman now works as Consultant in Supportive Care and Honorary Senior Lecturer at The Christie NHS Foundation Trust, Europe’s largest single-site cancer centre.

His main clinical interest concerns the early involvement of palliative care in cancer care.

Having pioneered a new approach to the delivery of palliative care in a cancer centre, he is now NHS England’s lead clinician for The Enhanced Supportive Care Initiative – a new programme to improve access to specialist supportive care for patients going through cancer treatment.